Vaneltix Pharma, Inc.
Clinical trials sponsored by Vaneltix Pharma, Inc., explained in plain language.
-
New bladder pain drug shows promise in early trial
Symptom relief Recruiting nowThis study tests a drug called VNX001 for people with Interstitial Cystitis (a condition causing bladder pain) who have sudden, moderate-to-severe pain. About 50 adults will receive up to 6 doses of the drug through a catheter over 14 days. The goal is to see if the drug safely r…
Phase: PHASE2 • Sponsor: Vaneltix Pharma, Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC
-
New bladder pain cocktail put to the test in phase 2 trial
Symptom relief Recruiting nowThis study tests a single dose of VNX001, a mix of lidocaine and heparin, to quickly relieve moderate to severe bladder pain in people with interstitial cystitis/bladder pain syndrome. About 120 adults will receive either the combination, one of its components, or a placebo. The …
Phase: PHASE2 • Sponsor: Vaneltix Pharma, Inc. • Aim: Symptom relief
Last updated May 05, 2026 11:54 UTC